Evaluation of cfDNA as an early detection assay for dense tissue breast cancer

Abstract A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. Recently, investigations of cfDNA as a reliable early detection bioassay have presented a p...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Mouadh Barbirou, Amanda A. Miller, Erik Gafni, Amel Mezlini, Asma Zidi, Nathan Boley, Peter J. Tonellato
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Online Access:https://doi.org/10.1038/s41598-022-12457-1